About a week ago, the FTC filed a suit against Endo Pharmaceuticals (among others) for blocking generic competition of its Opana ER and Lidoderm products. It is alleging that in addition to paying to delay competitive products, Endo used a no-AG commitment that gave Watson Laboratories more than 7 months of their own monopoly on…
Researchers often neglect to search antibody patents because it seems complex and due to the perception that there is nothing to be gained from it. Dangerous thinking! Antibody search, with the right tools, is in fact quite easy. And the gain is compelling: searching patents is the best way to learn about the competitive landscape…